A therosclerotic plaque rupture and subsequent thrombus formation in the culprit lesion are recognized to be the seminal events in the majority of cases of acute coronary syndrome. Plaque stability is determined by many factors, including lipid deposits, oxidative stress, inflammation, and extracellular matrix degradation.
A therosclerotic plaque rupture and subsequent thrombus formation in the culprit lesion are recognized to be the seminal events in the majority of cases of acute coronary syndrome. Plaque stability is determined by many factors, including lipid deposits, oxidative stress, inflammation, and extracellular matrix degradation. [1] [2] [3] [4] Accumulation of lipid in the atherosclerotic lesion increases mechanical stress within the fibrous cap. 5 In addition, modification of low-density lipoprotein (LDL) by oxidative stress results in the avid uptake of these lipoproteins via infiltrating macrophages, which induces macrophage activation and foam cell formation. 6 The activation of macrophages in atherosclerotic plaques leads to the secretion of inflammatory cytokines and proteolytic enzymes capable of degrading the extracellular matrix, and these changes consequently increase plaque vulnerability. 7 Angiotensin II (Ang II) is well known to mediate cardiovascular disease pathogenesis by regulating oxidative stress, inflammation, and cell proliferation. We previously demonstrated that the angiotensin II type 1a (AT 1a ) receptor enhances neointimal formation after cuff-induced vascular injury as well as high-fat diet-induced atherosclerotic lesion formation in apolipoprotein E (ApoE) −/− mice, and that the AT 2 receptor counterregulates AT 1a receptor-mediated lesion formation. [8] [9] [10] [11] However, the role of the AT 1a receptor in atherosclerotic plaque rupture is poorly understood. In a previous study, we demonstrated that expression of the AT 1a receptor in atherosclerotic lesions was increased by feeding a high-cholesterol diet to ApoE −/− mice. 10 Ang II receptor blockade significantly inhibited lipid accumulation and oxidative stress in the atherosclerotic lesions of ApoE −/− mice fed a high-cholesterol diet. 9, 11 Moreover, Ang II receptor deletion prevents vascular oxidative stress, endothelial dysfunction and atherosclerotic lesion formation in ApoE −/− mice, irrespective of blood pressure and plasma cholesterol levels. 12 These results suggest that the AT 1a receptor may play a critical role in atherosclerotic plaque vulnerability.
Several models of plaque rupture in ApoE −/− mice have been used for investigating the mechanisms responsible for plaque vulnerability. These models have included chow feeding for about a year, 13 high-fat feeding for about 2 months, 14 and cuff placement and subsequent adenovirus-mediated transfer of p53. 15 Recently, carotid artery ligation and cuff placement in ApoE −/− mice was shown to be a simple and highly efficient method of inducing plaque rupture. 16 This plaque rupture model partially overlaps with human disease as cracks in the neointima and thrombus formation were consistently observed in the section of the carotid artery surrounded by the cuff.
In this study, we tested the hypothesis that the AT 1a receptor contributes to plaque vulnerability by analyzing the incidence of plaque rupture after carotid artery ligation and cuff placement in ApoE −/− , ApoE −/− AT 1a −/− , ApoE −/− AT 1a +/− , and ApoE −/− mice treated with valsartan. We showed that deletion of the AT 1a receptor as well as treatment with valsartan prevented plaque rupture in ApoE −/− mice, and this was associated with decreased lipid accumulation, macrophage infiltration, oxidative stress, and matrix metalloproteinase (MMP) activity. Moreover, we showed that the AT 1a receptor modulates CD36-dependent macrophage migration.
Materials and Methods
An expanded Materials and Methods section is available in the online-only Data Supplement.
Animals
All animal studies were approved by the Animal Studies Committee of Ehime University. Male ApoE −/− mice were purchased from Jackson Laboratory (Bar Harbor, ME). ApoE −/− AT 1a −/− with the same C57BL/6J genetic background were generated by crossing ApoE −/− and AT 1a −/− mice (donated by Tanabe Seiyaku Co. Ltd., Osaka, Japan). ApoE −/− AT 1a +/− mice were generated by crossing ApoE −/− and ApoE −/− AT 1a −/− mice. During the experimental period, they were provided standard chow (MF, Oriental Yeast Co. Ltd., Tokyo, Japan) and water ad libitum.
Murine Model of Atherosclerotic Plaque rupture
We generated a murine model of atherosclerotic plaque rupture as previously reported. [16] [17] [18] In brief, 9-week-old mice were anesthetized with an intraperitoneal injection of pentobarbital sodium (50 mg/kg), and then their common carotid artery was ligated just proximal to the bifurcation. Four weeks after ligation, a polyethylene cuff (length 2 mm; inside and outside diameter of 0.580 mm and 0.965 mm, respectively; IMG Imamura Co. Ltd., Tokyo, Japan) was placed around the common carotid artery, just proximal to the ligated site. The intracuff lesions were evaluated at 4 days after cuff placement. Valsartan (purchased from Tokyo Chemical Industry Co. Ltd., Tokyo, Japan; 1mg/kg per day) was administered intraperitoneally via an implanted osmotic minipump starting 1 week before cuff placement.
statistical Analysis
All values for continuous variables are expressed as the mean±SEM and represent data from at least 3 independent experiments. Values for categorical variables are expressed as the number of animals or incidence of events. For continuous variables, groups were compared with a 1-way ANOVA followed by Scheffe post hoc test. Figure 1A-1D ). The incidence of plaque rupture with thrombus was significantly reduced in ApoE −/− AT 1a −/− mice compared with ApoE −/− mice (72% versus 24%, respectively; P<0.01; Figure 1E ). Similarly, valsartan significantly reduced plaque rupture in ApoE −/− mice from 72% to 25% (P<0.01; Figure 1E ). There was no significant difference in the incidence of plaque rupture between ApoE −/− and ApoE −/− AT 1a +/− mice (72% versus 50%, respectively; Figure 1E ). 19 we next examined lipid accumulation and macrophage infiltration into plaques. There were no significant differences in plasma total cholesterol and LDL cholesterol levels between ApoE −/− and ApoE −/− AT 1a −/− mice (data not shown). The expression of AT 2 receptors was examined in the carotid arteries by immunohistochemical staining before and after ligation, and cuff placement, and AT 2 receptor expression increased to the same extent in both ApoE −/− and ApoE −/− AT 1a −/− mice ( Figure I in the online-only Data Supplement). To visualize lipid-rich atherosclerotic plaques, fresh-frozen sections were stained with oil red O. At 4 days after cuff placement, abundant lipid accumulation in plaques and infiltration of F4/80-positive macrophages were observed in ApoE −/− mice (Figure 2A and 2D ). In contrast, these changes were clearly attenuated in ApoE −/− AT 1a −/− mice ( Figure 2B and 2E) and ApoE −/− mice treated with valsartan ( Figure 2C and 2F). Because inflammation is central at all stages of atherosclerosis and inflammatory cytokines involved in atherogenesis, 7 we examined the expression of proinflammatory cytokines in the carotid lesions to determine the role of the AT 1a receptor in mediating inflammation in rupture-prone plaques. The protein expression of both tumor necrosis factor- and interleukin 6 was significantly attenuated in ApoE 
deletion of the AT 1a receptor Prevents Oxidized ldl-induced Macrophage Trapping
Excessive uptake of lipid-rich particles by scavenger receptors results in transformation of macrophages into foam cells, and the trapping of the cells in the atherosclerotic plaque is a critical step in atherosclerosis. An increased number of monocyte-derived cells in progressive atherosclerotic plaques is associated not only with robust recruitment of monocytes into lesions, but also with a depressed rate of their migratory clearance from the lesions. 20 To investigate the mechanism by which AT 1a receptor deficiency decreases macrophage infiltration into carotid lesions ( Figure 2E ), we next examined the migration activity of mouse peritoneal macrophages. We harvested resident (not thioglycolate-elicited) mouse peritoneal macrophages to avoid basal activation. CD36, a member of the scavenger receptor class B family with a capacity to bind oxidized LDL as well as various other ligands, has been shown to transduce signals that regulate inflammatory responses in macrophages. 22 Oxidized LDL can stimulate its own uptake by induction of CD36 gene expression. 23 Moreover, CD36 signaling in response to oxidized LDL alters cytoskeletal dynamics to inhibit macrophage migration. 21 To investigate the mechanism by which AT 1a receptor deficiency inhibits oxidized LDL-induced macrophage trapping, we next examined the time course of CD36 protein expression after oxidized LDL stimulation in ApoE −/− and ApoE −/− AT 1a −/− resident mouse peritoneal macrophages by Western blot analysis. Enhanced CD36 expression was observed following 6 hours of exposure to oxidized LDL (50 μg/mL) with abundant expression at 8 hours in ApoE −/− macrophages, whereas the CD36 protein level did not change in ApoE −/− AT 1a −/− macrophages ( Figure 6 ). The mechanism of oxidized LDL-induced macrophage trapping has been postulated to involve both CD36-and Src kinase-dependent direct activation of focal adhesion kinase (FAK) and indirect activation of FAK by Src homology 2 domain-containing phosphotyrosine phosphatase (SHP-2) inactivation via CD36-mediated reactive oxygen species. 21 To investigate the effect of AT 1a receptor deficiency for activation of FAK and inhibition of SHP-2, we examined the time course of FAK and SHP-2 phosphorylation after oxidized LDL stimulation in ApoE −/− and ApoE −/− AT 1a −/− resident mouse peritoneal macrophages. FAK phosphorylation was significantly attenuated in ApoE −/− AT 1a −/− macrophages compared with ApoE −/− macrophages ( Figure VA and VB in the onlineonly Data Supplement). Phosphorylation of Tyr-580 of SHP-2 has been reported to stimulate SHP-2 tyrosine phosphatase activity. 24 In the present study, phosphorylation of Tyr-580 of SHP-2 tended to be higher in ApoE −/− AT 1a −/− macrophages compared with ApoE −/− macrophages, but the difference was not statistically significant ( Figure VC and VD in the online-only Data Supplement). These results suggest that CD36-and Src kinasedependent direct activation of FAK is a dominant pathway for oxidized LDL-induced macrophage trapping in our experimental model. C-Jun N-terminal kinase (JNK) 2 is a key downstream kinase of CD36-dependent signaling. It has been reported that exposing peritoneal macrophages from wild type but not CD36 −/− mice to oxidized LDL leads to activation of JNK2 and that pharmacological blockade of JNK inhibits CD36-dependent foam cell formation in vitro and in vivo. 25 Therefore, we also examined the effect of AT 1a receptor deficiency on oxidized LDL-induced JNK2 activation in resident mouse peritoneal macrophages. As shown in Figure VI in the online-only Data Supplement, phosphorylation of JNK2 was observed following 10 minutes of exposure to oxidized LDL (50 μg/mL) and was sustained for 60 minutes in ApoE −/− macrophages. In contrast, oxidized LDLinduced phosphorylation of JNK2 was significantly attenuated in ApoE −/− AT 1a −/− macrophages. Moreover, we confirmed that the phosphorylation of JNK2 in the carotid lesions was also significantly attenuated in ApoE −/− AT 1a −/− mice as compared with ApoE −/− mice ( Figure VII in the online-only Data Supplement). The lipoxygenase (LO) pathway is involved in LDL oxidation and the pathogenesis of atherosclerosis. Angiotensin II has been shown to upregulate 12-LO activity and expression in human aortic smooth muscle cells. 26 Moreover, it has been reported that the LO pathway mediates AngII-induced JNK activation 27 and impairs the macrophage ATP-binding cassette transporter G1 for cholesterol efflux. 28, 29 In this study, expression of 12/15 LO protein in the carotid lesions tends to be lower in ApoE 
discussion
The major findings of this study were that AT 1a receptor deficiency and AT 1a receptor pharmacological blockade in vivo significantly reduced the incidence of atherosclerotic plaque rupture. We showed that the inhibitory effect of the AT 1a receptor on plaque rupture was associated with attenuation of lipid accumulation, macrophage infiltration, inflammation, superoxide anion production, NADPH oxidase activation, and MMP activation in the lesion. We also showed that inhibition of CD36 expression, and FAK and JNK activation are important mechanisms by which AT 1a receptor deficiency attenuates macrophage burden, macrophage trapping into the atherosclerotic plaque and foam cell formation. To our knowledge, these findings are the first to demonstrate that AT 1a receptor deficiency can prevent atherosclerotic plaque rupture.
Two large randomized clinical trials have shown that angiotensin-converting enzyme inhibition or Ang II receptor blockade reduces the risk of major events including cardiovascular death, myocardial infarction, or stroke. 30, 31 However, few studies have investigated the effect of the AT 1a receptor on atherosclerotic plaque rupture. In a previous study, we showed that Ang II receptor blockade significantly inhibited lipid accumulation and oxidative stress in atherosclerotic lesions in ApoE −/− mice fed a high-cholesterol diet, suggesting that AT 1a receptor-mediated signaling enhances plaque vulnerability. Moreover, Ang II receptor blockade with irbesartan has been reported to decrease inflammation and MMP expression in human carotid plaques. 32 These observations led us to study the effect of AT 1a receptor deficiency on atherosclerotic plaque rupture.
MMPs can degrade the major components of the vascular extracellular matrix including the fibrous cap of atherosclerotic plaque. Activation of MMPs by monocyte/macrophages could therefore promote plaque instability. Ang II has been reported to increase the activity of MMPs through AT 1a receptor stimulation. 33 Because reactive oxygen species enhance matrix degradation by activating type IV collagenases, oxidative stress might be involved in the mechanism of activation of MMPs by the AT 1a receptor. Indeed, we have previously reported that AT 1a receptor stimulation by Ang II induces oxidative stress through phosphorylation of p47phox and translocation of p47phox and Rac1 to the plasma membrane fraction. 10 In the present study, we showed that superoxide anion production, NADPH oxidase activity and the activity of type IV collagenases in carotid lesions were significantly attenuated in ApoE −/− AT 1a −/− and ApoE −/− mice treated with valsartan compared with ApoE −/− mice. These results suggest that AT 1a receptor blockade contributes to plaque stability in part by attenuating oxidative stress and activation of MMPs.
Macrophage CD36 has been shown to transduce signals that regulate inflammatory responses and foam cell formation by mediating macrophage migration and the uptake of oxidized LDL. 25, 34, 35 CD36 signaling in response to oxidized LDL has also been shown to alter cytoskeletal dynamics to inhibit macrophage migration. 21 Thus, CD36 plays a critical role in oxidized LDL-induced macrophage trapping in atherosclerotic lesions, foam cell formation, and inflammatory responses. To understand the mechanism by which AT 1a receptor deficiency attenuates macrophage infiltration into the lesion, we performed a macrophage migration assay. Consistent with a previous report, 21 we showed that monocyte chemoattractant protein-1-induced migration was significantly inhibited by oxidized LDL in ApoE −/− macrophages. Interestingly, the inhibitory effect of oxidized LDL on migration was completely abolished in ApoE −/− AT 1a −/− macrophages. In addition, we showed that oxidized LDL-induced CD36 expression, FAK, and JNK2 phosphorylation were significantly attenuated in ApoE −/− AT 1a −/− macrophages compared with ApoE −/− macrophages. These results suggest that AT 1a receptor deficiency contributes to the inhibition of foam cell formation as well as macrophage emigration from lesions by attenuating CD36 expression, FAK, and JNK2 activation. Recently, deletion of the ATP-binding cassette transporters ABCA1 and ATP-binding cassette transporter G1 has been reported to impair macrophage migration through increased Rac1 signaling. 36 We confirmed that ABCA1 protein expression in carotid lesions was significantly increased in ApoE −/− AT 1a −/− mice compared with ApoE −/− mice. Indeed, Ang II has been shown to transcriptionally repress ABCA1 gene expression via the AT 1a receptor. 37 Thus, ABCA1 could be involved in AT 1a receptor-regulated macrophage migration. Inflammation at sites of atherosclerotic plaques is thought to be a major factor for the progression of atherosclerotic disease, and proinflammatory cytokine may reflect inflammatory activity in the plaques. In agreement with this notion, we showed that AT 1a receptor deletion reduced the expression of proinflammatory cytokines (interleukin 6 and tumor necrosis factor ) in the carotid lesions. The LO pathway also regulates inflammatory responses in the atherosclerotic plaque, and has been reported to contribute to atherogenesis via initiation of LDL oxidation and foam cell generation. The expression of 12/15 LO protein in the carotid lesions tended to be lower in ApoE −/− AT 1a −/− mice as compared with ApoE −/− mice, although the difference did not reach statistical significance. This tendency suggests that inhibition of the LO pathway may represent 1 of the vascular protective effects of AT 1a receptor blockade.
Several limitations of this study should be noted. First, this study was carried out in a mouse model of atherosclerotic plaque rupture that mimics only some aspects of the human disease such as reduced collagen content, increased MMP activity, and apoptotic cells. 16 Second, the mechanism by which AT 1a receptor deficiency suppresses oxidized LDL-induced CD36 expression is unclear. Although oxidized LDL 38 as well as Ang II 39 have been shown to upregulate CD36 expression, further investigations are necessary to understand the signaling crosstalk between the AT 1a receptor and CD36.
In summary, the present study suggests that the AT 1a receptor modulates oxidized LDL-induced macrophage CD36 expression, and FAK and JNK2 activity, and deletion of this receptor increases plaque stability. Furthermore, pharmacological blockade of the AT 1a receptor may have similar beneficial effects on atherosclerotic plaque stability via attenuation of macrophage trapping in atherosclerotic lesions, foam cell formation, inflammation, superoxide production, and activation of MMPs. These results provide new insight into the mechanisms responsible for atherosclerotic plaque rupture. 
Superoxide Detection
Histological detection of superoxide anion in situ was performed using fresh-frozen sections stained with dihydroethidium (DHE; 10 mol/L) in PBS for 30 minutes at 37C in a moisture 2 box. 1 The intensity of the fluorescence signal was analyzed and quantified using Densitograph
Imaging Software (ATTO Corporation, Tokyo, Japan).
NADPH oxidase activity
The carotid arteries in the cuff were homogenized in 150 µl of ice-cold 
In Situ Gelatin Zymography
In situ detection of gelatinolytic activity was performed with a fluorogenic gelatin substrate, DQ-gelatin (Invitrogen, CA). 2 Fresh-frozen sections (10 m) of carotid artery were incubated with DQ-gelatin for 30 minutes at 37C in a moisture box according to the manufacturer's instructions. This procedure enabled localization of MMP-2 and MMP-9 activity in the carotid artery. Gelatinolytic activity was visualized under a fluorescence (530 nm) microscope.
Negative control sections were incubated in the same way as described above, but without DQ-gelatin. Quantitative analysis was performed with Densitograph Imaging Software (ATTO Corporation, Tokyo, Japan). 
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